Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desogestrel/Ethinyl Estradiol for PCOS (Real-World, Multicenter)
ChiCTR2500104048Phase 4Not yet recruiting
- Sponsor
- Sichuan Provincial Maternal and Child Health Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ethinyl estradiol + desogestrel in polycystic ovary syndrome (PCOS), sponsored by Sichuan Provincial Maternal and Child Health Hospital. Primary endpoint: Proportion of patients with normal menstrual cycle frequency within 3 cycles. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
ethinyl estradiol + desogestrel
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR2500104048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104048.